These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18081629)

  • 21. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G; Bossie C; Turkoz I; Kujawa M; Mahmoud R; Simpson G
    J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Social outcome of schizophrenics in Tunisia: a transversal study of 60 patients].
    Rafrafi R; Zaghdoudi L; Mahbouli M; Bouzid R; Labbane R; El Hechmi Z
    Encephale; 2009 Jun; 35(3):234-40. PubMed ID: 19540409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic nervous system activity and psychiatric severity in schizophrenia.
    Fujibayashi M; Matsumoto T; Kishida I; Kimura T; Ishii C; Ishii N; Moritani T
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):538-45. PubMed ID: 19496998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia.
    Nasrallah H; Morosini P; Gagnon DD
    Psychiatry Res; 2008 Nov; 161(2):213-24. PubMed ID: 18848731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy in pregnant women with major psychiatric illness: a pilot study.
    Peindl KS; Masand P; Mannelli P; Narasimhan M; Patkar A
    J Psychiatr Pract; 2007 Nov; 13(6):385-92. PubMed ID: 18032983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy and atypical antipsychotics.
    Ruzić K; Dadić-Hero E; Knez R; Medved P; Petrić D
    Psychiatr Danub; 2009 Sep; 21(3):368-70. PubMed ID: 19794358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ; Nakonezny PA; Rush AJ
    Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric evaluation of the Multidimensional Assessment of Fatigue scale for use with pregnant and postpartum women.
    Fairbrother N; Hutton EK; Stoll K; Hall W; Kluka S
    Psychol Assess; 2008 Jun; 20(2):150-8. PubMed ID: 18557692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denial of pregnancy--characteristics of women at risk.
    Wessel J; Gauruder-Burmester A; Gerlinger C
    Acta Obstet Gynecol Scand; 2007; 86(5):542-6. PubMed ID: 17464581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study.
    Gaite L; Vázquez-Barquero JL; Herrán A; Thornicroft G; Becker T; Sierra-Biddle D; Ruggeri M; Schene A; Knapp M; Vázquez-Bourgon J;
    Compr Psychiatry; 2005; 46(6):440-6. PubMed ID: 16275211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.